Abstract
Hyperlipidemia is increasing prevalent risk factor in children, concomitant with worldwide epidemic of obesity. Lipid disorder can occur either as primary event or secondary to an underlying disease. The primary dyslipidemia are associated with overproductions/or impaired removal of lipoprotein. The latter defect can be induced by an abnormality in either the lipoprotein itself or in the lipoprotein receptor. A 2 month old male baby was found to have highly viscous and milky serum. S. Cholesterol was 2,200 mg/dl and triglycerides 13,292 mg%. There was no dysmorphic feature. Child was anemic and had hepatosplenomegaly and xanthomas. There was positive history of hyperlipidemia in first maternal cousin. Parents of index case had normal lipid profile. The child was put on lipid lowering agents, Iron drops, medium chain fatty acid.
References
Santamarina-Fojo S. The familial chylomicronemia syndrome. Endocrinol Metab Clin North Am. 1998;27(3):551–67.
Feoli-Fonseca JC, Levy E, Godard M, Lambert M. Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study. J Pediatr. 1998;133(3):417–23.
Brunzell JD, Miller NE, Alaupovic P. Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. J Lipid Res. 1983;24(1):12–9.
Yuan G, Al-Shali KJ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. Can Med Assoc J. 2007;176(8):1113–20.
Labossiere R, Goldberg IJ. Management of hypertriglyceridemia. Therapeutic lipidology. Totowa: Humana Press; 2008. p. 201–20.
Reina M, Brunzell JD, Deeb SS. Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes. J Lipid Res. 1992;33(12):1823–32.
Sugandhan S, Khandpur S, Sharma VK. Familial chylomicronemia syndrome. Pediatr Dermatol. 2007;24(3):323–5.
Nagar R, Arora U. An unusual case of familial hyperlipidaemia. Indian J Clin Biochem. 2008;23(3):302–4.
Rahalkar AR, Hegele RA. Monogenic pediatric dyslipidemias: classification, genetics and clinical spectrum. Mol Genet Metab. 2008;93(3):282–94.
Clauss SB, Kwiterovich PO. Genetic disorders of lipoprotein transport in children. Prog Pediatr Cardiol. 2003;17(2):123–33.
Ben-Avram CM, Ben-Zeev O, Lee TD. Homology of lipoprotein lipase to pancreatic lipase. Proc Natl Acad Sci USA. 1986;83(12):4185–9.
Wheeler KAH, West RJ, Lloyd JK, Barley J. Double blind trial of bezafibrate in familial hypercholesterolaemia. Arch Dis Child. 1985;60(1):34–7.
McCrindle BW. Hyperlipidemia in children. Thromb Res. 2006;118(1):49–58.
Colletti RB, Neufeld EJ, Roff NK, McAuliffe TL, Baker AL, Newburger JW. Niacin treatment of hypercholesterolemia in children. Pediatrics. 1993;92(1):78–82.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chaurasiya, O.S., Kumar, L. & Sethi, R.S. An Infant with Milky Blood : An Unusual but Treatable Case of Familial Hyperlipidemia. Ind J Clin Biochem 28, 206–209 (2013). https://doi.org/10.1007/s12291-012-0285-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-012-0285-9